PortfoliosLab logo

Athira Pharma, Inc. (ATHA)

Equity · Currency in USD · Last updated Feb 1, 2023

Company Info

ISINUS04746L1044
CUSIP04746L104
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$4.04
Year Range$2.74 - $13.51
EMA (50)$3.46
EMA (200)$5.34
Average Volume$347.39K
Market Capitalization$151.32M

ATHAShare Price Chart


Loading data...

ATHAPerformance

The chart shows the growth of $10,000 invested in Athira Pharma, Inc. in Aug 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $2,361 for a total return of roughly -76.39%. All prices are adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2023
11.58%
-1.81%
ATHA (Athira Pharma, Inc.)
Benchmark (^GSPC)

ATHACompare to other instruments

Search for stocks, ETFs, and funds to compare with ATHA

Athira Pharma, Inc.

ATHAReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M27.44%6.18%
YTD27.44%6.18%
6M20.96%-1.02%
1Y-59.60%-8.02%
5Y-45.74%9.09%
10Y-45.74%9.09%

ATHAMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202214.10%-2.87%-12.13%11.45%-6.04%1.93%

ATHASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Athira Pharma, Inc. Sharpe ratio is -0.65. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20SeptemberOctoberNovemberDecember2023
-0.65
-0.33
ATHA (Athira Pharma, Inc.)
Benchmark (^GSPC)

ATHADividend History


Athira Pharma, Inc. doesn't pay dividends

ATHADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%SeptemberOctoberNovemberDecember2023
-88.22%
-15.01%
ATHA (Athira Pharma, Inc.)
Benchmark (^GSPC)

ATHAWorst Drawdowns

The table below shows the maximum drawdowns of the Athira Pharma, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Athira Pharma, Inc. is 92.01%, recorded on Jun 24, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.01%Dec 24, 2020377Jun 24, 2022
-14.9%Oct 21, 20206Oct 28, 20205Nov 4, 202011
-13.58%Nov 16, 20208Nov 25, 202010Dec 10, 202018
-10.73%Oct 1, 20202Oct 2, 202011Oct 19, 202013
-10%Nov 5, 20202Nov 6, 20205Nov 13, 20207
-6.64%Dec 15, 20201Dec 15, 20202Dec 17, 20203
-6.37%Sep 21, 20204Sep 24, 20204Sep 30, 20208

ATHAVolatility Chart

Current Athira Pharma, Inc. volatility is 66.25%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%SeptemberOctoberNovemberDecember2023
66.25%
16.90%
ATHA (Athira Pharma, Inc.)
Benchmark (^GSPC)